Meng-Hua Chen

TL;DR: The findings expand the understanding on IgAN genetic susceptibility and provide novel biological insights into molecular mechanisms underlying IgAN, and correlate with geographical variation in IgAN prevalence.

TL;DR: In this paper, the adverse cardiovascular outcomes between insulin-treated and non-insulin treated type 2 diabetes mellitus patients after percutaneous coronary intervention (PCI) have been investigated.

TL;DR: This “obesity paradox” does exist after PCI and the mortality in overweight and obese patients is really significantly lower compared to the normal weight patients, however, the exact reasons need further exploration and research in the future.

TL;DR: CABG was associated with significantly lower long-term adverse clinical outcomes compared to PCI in patients with ITDM, however, due to an insignificantly higher rate of stroke in the CABG group, further researches with a larger number of randomized patients are required to completely solve this issue.

TL;DR: Insulin treatment in these DM patients was associated with a significantly higher short and long-term adverse cardiovascular outcomes after PCI compared to those DM patients not treated by insulin therapy.